varicella inggris
DESCRIPTION
kulitTRANSCRIPT
(CHICKEN POX)
• An acute, highly
contagious exanthem.
• Most often occurs in
childhood.
• Result of primary infection
of a susceptible individual.
EPIDEMIOLOGY
1.Worldwide in distribution,
whereas the proportion of
susceptible adults is even
higher in Asia, Africa, and
the Middle East.
2.No difference in racial or
sexual susceptibility.
3.Humans are the only
known reservoir.
4.Vectors play no role in
transmission.
5.The mean incubation
period is 14 or 15 days,
with a rarge of 10 to 23
days.
6.The major route by which
varicella is acquired and
transmitted is thought to
be the respiratory tract
7.Airborne droplets
constitute an important
mechanism of transmission,
but can also be spread by
direct contact
ETIOLOGY
1.VZV is a member of the
herpes virus family.
2.There is only one VZV
serotype.
3.A number of antigens are
present in the virion and
produced infected cells.
4.Studies of molecular
biology and its
pathogenesis have been
hampered.
PATHOGENESIS
1.Entry of the virus is
through the mucosa of
the upper respiratory
tract and oropharynx.
2.Initial multiplication at this portal dissemination small amounts of virus blood and lymphatics (primary viremia) by cells of RES.
3.Incubating infection is partially contaired by innate host defenses and by developing immune responses.
4.Virus replication eventually overwhelms these still undeveloped defenses secondary viremia occurs (zweeks often infection) fever and malaise and disseminates throughout the body especially skin and mucous membranes.
5.Cyclic viremia is terminate after about 3 days.
6.Host immune responses terminate viremia and limit the progression of varicella lesions.
7.IgG, IgM, and IgA of VZV are detectable 2 to 5 days after onset of clinical varicella.
8.Reach maximum titers during second or third week decline slowly persist in low levels for life
9.Cell mediated immunity is more important than humoral immunity in recovery from varicella.
CLINICAL MANIFESTATIONS
Prodrome of Varicella1.Uncommon in young
children.2.In older children and
adults, rash preceded by 2 to 3 day of fever , chills, malaise, headache, anorexia, severe backache.
Rash of Varicella1.Benigns on the face and
scalp.2.Spreads rapidy to the
trunk, with relative sparing of the extremities.
3.Central in distribution.4.More profuse in lows and
protected parts of the body.
5.Rose colored macules papule vesicles pustules crusts.
6.Vesicle is superficial and thin walled like a drop of water
7.Vesicle can also develop in the mucous membranes
8.Fever that persist is proportional to the severity of rash.
COMPLICATIONS OF VARICELLA
1.Secondary bacterial
infection of skin lesion
(children).
2.Primary varicella
pneumonia (adult).
3.Congenital VZV infection :
asymptomatic infection
severe congenital
malformation.
4.Morbidity and mortality
are markedly increased in
immuno compromised
patients.
5.CNS complication :• Reye’s syndrome.• Acute cerebellar atoxia.• Encephalitis or
meningoencephalitis.• Acute ascending or
transverse myelitis.• Guillain-barre
syndrome.6.Mild hepatitis.
PATHOLOGY
1.Histologically, can’t be
distinguished from herpes
zoster.
2.Ballooning degeneration
(characteristic changes).
CLINICAL DIAGNOSIS
1.The development papulo
vesikular eruption after a
brief and mild (or absent)
prodrome symptoms.
Characteristic diagnostic include:
2.Appearance of lesions in
crops with central
distribution.
3.Rapid evolution of lesions.
4.Presence of lesions in all
stages of development in
any area throughout the
acute disease.
5.Presence of lesions in
the mucous membranes
of the mouth.
LABORATORY DIAGNOSIS
1.Routine blood test are
not helpful.
2.Asymptomatic elevation
in ALT and AST.
3.Punch biopsies more
rediable for histologig
examinations.
4.Defenitive diagnosis from
isolation of virus in cell
cultures.
5.Serologic tests.
TREATMENT
Antiviral agents :
• Acyclovir.
• Famciclovir.
• Laciclovir.
• Vidarabine.
• Foscarnet.
TREATMENT OF VARICELLA
1.Generally benign and self-limited.
2.Locally :• Cool compresses.• Calamine lotion.
Orally :• Antihistamines.• Antipyretics.• Antiviral agents.
PREVENTION & CONTROL
1.Passive
immunization.
2.Chemoprophylactic.